Observational study of SARS-CoV-2 antibody test positive rate.

Observational study of SARS-CoV-2 antibody test positive rate. - Observational study of SARS-CoV-2 antibody test positive rate.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041262

Enrollment

4000

Registered

2020-08-01

Start date

2020-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1, A subject, willing to take SARS-CoV-2 antibody test, gives written consent to the study.

Exclusion criteria

Exclusion criteria: 1, A subject whose blood is difficult to collect. 2, A subject who the investigators think is not appropriate to the study.

Design outcomes

Primary

Measure	Time frame
SARS-CoV-2 antibody test positive rate.	—

Secondary

Measure	Time frame
Factors that influence on test positive rate	—

Countries

Japan

Contacts

Public ContactTatsuya Yoshihara

SOUSEIKAI Fukuoka Mirai Hospital Clinical Research Center

tatsuya-yoshihara@lta-med.com0926623608

Outcome results